* Surgery Partners Inc SGRY.OQ SGRY.O is expected
to show a
rise in quarterly revenue when it reports results on May 1.
* The Brentwood Tennessee-based company is expected to
report a
10.2% increase in revenue to $657.102 million from $596.2
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Surgery Partners
Inc is
for breakeven results per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Surgery
Partners
Inc is $43, above its last closing price of $39.27.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.19 0.19 0.27 Beat 45.9
Sep. 30 2022 0.03 0.05 -0.02 Missed -143.8
Jun. 30 2022 -0.01 -0.01 -0.03 Missed -344.4
Mar. 31 2022 -0.06 -0.06 -0.09 Missed -47.5
Dec. 0.21 0.19 0.23 Beat 18.7
31 2021
Sep. 30 2021 -0.11 -0.10 -0.05 Beat 52.1
Jun. 30 2021 -0.20 -0.18 0.00 Beat 100
Mar. 31 2021 -0.36 -0.37 -0.30 Beat 19.2
This summary was machine generated April 28 at 20:20 GMT. All
figures in US dollars unless otherwise stated